Dicerna Pharmaceuticals

-$0.04 (-0.11%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRNA and other ETFs, options, and stocks.

About DRNA

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas.

CEO
Douglas M. Fambrough
Employees
302
Headquarters
Lexington, Massachusetts
Founded
2006

DRNA Key Statistics

Market Cap
2.84B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
662.36K
High Today
$37.29
Low Today
$35.89
Open Price
$37.01
Volume
499.45K
52 Week High
$40.14
52 Week Low
$16.50

DRNA News

Simply Wall St23h

Did Dicerna Pharmaceuticals, Inc. Insiders Buy Up More Shares?

We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be remiss not to mention that insider sales ha

DRNA Earnings

-$0.58
-$0.20
$0.17
$0.55
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure